Urology
Volume 59, Issue 6 , Pages 803-810 , June 2002

Quality of life and erectile dysfunction

  • Stanley E Althof

      Affiliations

    • S. E. Althof is a consultant to Pfizer, Inc. regarding the development of a Quality of Life Protocol.
    • Corresponding Author InformationReprint requests: Stanley E. Althof, Ph.D., Center for Marital and Sexual Health, Case Western Reserve University School of Medicine, 23230 Chagrin Boulevard, Suite 350, Beachwood, OH 44122 USA
    • Center for Marital and Sexual Health, Case Western Reserve University School of Medicine, Beachwood, Ohio, USA

Received 14 November 2001 ,Revised 4 February 2002 ,Accepted 4 February 2002.

References 

  1. Feldman HA, Goldstein I, Hatzichristou DG, et al.  Impotence and its medical and psychosocial correlates (results of the Massachusetts Male Aging Study). J Urol. 1994;151:54–61
  2. Althof SE, Seftel AD. The evaluation and management of erectile dysfunction. Psychiatry Clin North Am. 1995;18:171–192
  3. Litwin MS, Hays RD, Fink A, et al.  Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995;273:129–135
  4. Litwin MS, McNaughton-Collins M, Fowler FJ, et al.  The National Institutes of Health chronic prostatitis symptom index (development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network). J Urol. 1999;162:369–375
  5. Litwin MS. Health-related quality of life in older men without prostate cancer. J Urol. 1999;161:1180–1184
  6. Altwein J, Ekman P, Barry M, et al.  How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium. Urology. 1997;49:66–76
  7. Gralnek D, Wessells H, Cui H, et al.  Differences in sexual function and quality of life after nerve sparing and nonnerve sparing radical retropubic prostatectomy. J Urol. 2000;163:1166–1170
  8. Calais Da Silva F, Marquis P, Deschaseaux P, et al.  Relative importance of sexuality and quality of life in patients with prostatic symptoms. Eur Urol. 1997;31:272–280
  9. Zlotta AR, Schulman CC. BPH and sexuality. Eur Urol. 1993;36(suppl 1):107–112
  10. Burger B, Weidner W, Altwein JE. Prostate and sexuality (an overview). Eur Urol. 1999;35:177–187
  11. Cummings MH, Alexander WD. Erectile dysfunction in patients with diabetes. Hospital Med. 1999;60:638–644
  12. Hultling C, Giuliano F, Quirk F, et al.  Quality of life in patients with spinal cord injury receiving Viagra® (sildenafil citrate) for the treatment of erectile dysfunction. Spinal Cord. 2000;38:363–370
  13. Miller J, Fowler C, Sharief M. Effect of Viagra (sildenafil citrate) on quality of life in men with erectile dysfunction and multiple sclerosis. Ann Neurol. 1999;46:496
  14. Rosas SE, Joffe M, Franklin E, et al.  Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int. 2001;59:2259–2266
  15. Araujo AB, Durante R, Feldman HA, et al.  The relationship between depressive symptoms and male erectile dysfunction (cross-sectional results of the Massachusetts Male Aging Study). Psychosom Med. 1998;60:458–465
  16. Seidman SN, Roose SP. The relationship between depression and erectile dysfunction. Curr Psychiatry Rep. 2000;2:201–205
  17. Jonler M, Moon T, Brannan W, et al.  The effect of age, ethnicity and geographical location on impotence and quality of life. Br J Urol. 1995;75:651–655
  18. Fugl-Meyer AR, Lodnert G, Bränholm I-B, et al.  On life satisfaction in male erectile dysfunction. Intern J Impot Res. 1997;9:1414–1418
  19. Rosen RC. Quality of life assessment in sexual dysfunction trials. Int J Impot Res. 1998;10(suppl 2):S21–S23
  20. Fugl-Meyer KS. Erectile problems (the perspective of the female). Scand J Urol Nephrol. 1998;32(suppl 197):12
  21. Williams JL. Ready, set, stop (reflections on assessing quality of life and the WHOQOL-100 (U.S. version)—World Health Organization Quality of Life). J Clin Epidemiol. 2000;53:13–17
  22. Williams G, Abbou C-C, Amar ET, et al.  The effect of transurethral alprostadil on the quality of life of men with erectile dysfunction and their partners. MUSE Study Group. Br J Urol. 1998;82:847–854
  23. Rosen RC, Riley A, Wagner G, et al.  The International Index of Erectile Function (IIEF) (a multidimensional scale for assessment of erectile dysfunction). Urology. 1997;49:822–830
  24. Althof SE, Cory EW, Levine SB, et al.  EDITS (development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction). Urology. 1999;53:793–799
  25. Althof SE, Turner LA, Levine SB, et al.  Through the eyes of women (the sexual and psychological responses of women to their partner’s treatment with self-injection and external vacuum therapy). J Urol. 1992;147:1024–1037
  26. Parkerson GH, Willke RJ, Hays RD. An international comparison of the reliability and responsiveness of the Duke health profile for measuring health-related quality of life of patients treated with alprostadil for erectile dysfunction. Med Care. 1999;37:56–67
  27. Willke RJ, Yen W, Parkerson GR, et al.  Quality of life effects of alprostadil therapy for erectile dysfunction (results of a trial in Europe and South Africa). Int J Impot Res. 1998;10:239–246
  28. Sandhu D, Curless E, Dean J, et al.  A double-blind, placebo controlled study of intracavernosal vasoactive intestinal polypeptide and phentolamine mesylate in a novel auto-injector for the treatment of non-psychogenic erectile dysfunction. Int J Impot Res. 1999;11:91–97
  29. Purvis K, Egdeveit I, Christiansen E. Intracavernosal therapy for erectile failure—impact of treatment and reasons for drop-out and dissatisfaction. Int J Impot Res. 1999;11:287–299
  30. Giuliano F, Pena BM, Mishra A, et al.  Efficacy results and quality-of-life measures in men receiving sildenafil citrate for the treatment of erectile dysfunction. Qual Life Res. 2001;10:359–369
  31. Paige NM, Hays RD, Litwin MS, et al.  Improvement in emotional well-being and relationship of users of sildenafil citrate. J Urol. 2001;166:1774–1778
  32. Seidman SN, Roose SP, Menza MA, et al.  Treatment of erectile dysfunction in men with depressive symptoms (results of a placebo-controlled trial with sildenafil citrate). Am J Psychiatry. 2001;158:1623–1630
  33. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483
  34. Neugarten BL, Havighurst RJ, Tobin SS. The measurement of life satisfaction. J Gerontol. 1961;16:134–138
  35. Perez MA, Meyerowitz BE, Lieskovsky G, et al.  Quality of life and sexuality following radical prostatectomy in patients with prostate cancer who use or do not use erectile aids. Urology. 1997;50:740–746
  36. Siegel T, Moul JW, Spevak M, et al.  The development of erectile dysfunction in men treated for prostate cancer. J Urol. 2001;165:430–435
  37. Carson CC, Patel MP. The epidemiology, anatomy, physiology and treatment of erectile dysfunction in chronic renal failure patients. Adv Ren Replace Ther. 1999;6:296–309
  38. Wagner TH, Patrick DL, McKenna P, et al.  Cross-cultural development of a quality of life measure for men with erectile difficulties. Qual Life Res. 1996;5:443–449
  39. Ventegodt S. Sex and the quality of life in Denmark. Arch Sex Behav. 1998;27:295–307
  40. O’Leary MP. Clinical trials in sexual dysfunction. Int J Impot Res. 1998;10(suppl 10):S7–S12
  41. Cassileth BR, Soloway MS, Vogelzang NJ, et al.  Patients’ choice of treatment in stage D prostate cancer. Urology. 1989;33(5 suppl):57–62
  42. Litwin MS, Nied RJ, Dhanani N. Health-related quality of life in men with erectile dysfunction. J Gen Intern Med. 1998;13:159–166
  43. Jardin A, Wagner G, Khoury S, et al.  Recommendations of the 1st International Consultation on Erectile Dysfunction. 1999; Paris

PII: S0090-4295(02)01606-0

Urology
Volume 59, Issue 6 , Pages 803-810 , June 2002

Article Tools